Shorter GGN Repeats in Androgen Receptor Gene Would Not Increase the Risk of Prostate Cancer.

Li J1,2, Xiao F1,3, Zhang Y1, Lan A1,3, Song Q3, Zhang R1,3, Gu K1, Chen P4, Li Z4, Zhang X4, Yang X1.

Author information

Abstract

The association between the polymorphic GGN repeat in androgen receptor gene and prostate cancer susceptibility has been studied extensively. But the results of these polymorphisms with prostate cancer risk remain inconclusive. Previous meta-analysis showed short GGN repeats (≤16 repeats) had high risks for prostate cancer compared with longer GGN repeats (>16 repeats). Many studies have been published since the release of the previous meta-analysis. Here, we conducted an updated meta-analysis to demonstrate whether short repeats have higher risks for prostate cancer compared to long repeats. Five databases (PubMed, EMBASE, Cochrane Library, The China National Knowledge Infrastructure, and Web of Science) were last searched until January 1, 2016. Random- or fixed-effects model was performed based on the heterogeneity among studies. The potential publication bias was assessed via Begg funnel plot and Egger regression test. Twelve out of 157 studies were extracted. The result indicated that there was no significant difference between short repeat group and long repeat group in the overall analysis ( I2 = 80.6%, P = .000, odds ratio = 1.31, 95% confidence interval: 0.93-1.83). There was no association between the length of GGN repeats and the occurrence of prostate cancer in both Caucasian and African American ( I2 = 6.7%, P = .359, odds ratio = 1.11, 95% confidence interval: 0.94-1.32; and I2 = 74.1%, P = .050, odds ratio = 0.963, 95% confidence interval: 0.36-2.58). Our result demonstrated that a shorter GGN repeat polymorphism cannot increase the risk of prostate cancer compared to the longer GGN repeats. That's different with previous meta-analysis.

KEYWORDS:

GGN repeats; androgen receptor; gene; meta-analysis; prostate cancer

PMID:: 28279145
DOI:: 10.1177/1533034616673272

From HuGE Literature Finder Database

This database contains published literature on genetic associations and other human genome epidemiology

Shorter GGN Repeats in Androgen Receptor Gene Would Not Increase the Risk of Prostate Cancer.
Technology in cancer research & treatment 2017 Apr 16 (2): 159-166.
Li Jiatong, Xiao Feifan, Zhang Yuening, Lan Aihua, Song Qian, Zhang Ruoheng, Gu Kailong, Chen Ping, Li Zhuo, Zhang Xinhua, Yang Xiao
Association between variants in genes involved in the immune response and prostate cancer risk in men randomized to the finasteride arm in the Prostate Cancer Prevention Trial.
The Prostate 2017 Mar .
Winchester Danyelle A, Till Cathee, Goodman Phyllis J, Tangen Catherine M, Santella Regina M, Johnson-Pais Teresa L, Leach Robin J, Xu Jianfeng, Zheng S Lilly, Thompson Ian M, Lucia M Scott, Lippman Scott M, Parnes Howard L, Isaacs William B, De Marzo Angelo M, Drake Charles G, Platz Elizabeth
Environmental factors and risk of aggressive prostate cancer among a population of New Zealand men - a genotypic approach.
Molecular bioSystems 2017 Mar .
Vaidyanathan Venkatesh, Naidu Vijay, Kao Chi Hsiu-Juei, Karunasinghe Nishi, Bishop Karen S, Wang Alice, Pallati Radha, Shepherd Phillip, Masters Jonathan, Zhu Shuotun, Goudie Megan, Krishnan Mohanraj, Jabed Anower, Marlow Gareth, Narayanan Ajit, Ferguson Lynnette
HOTAIR genetic variants are associated with prostate cancer and benign prostate hyperplasia in an Iranian population.
Gene 2017 Mar .
Taheri Mohammad, Habibi Mohsen, Noroozi Rezvan, Rakhshan Azadeh, Sarrafzadeh Shaghayegh, Sayad Arezou, Omrani Mir Davood, Ghafouri-Fard Soud
Relationship of oestrogen receptor alpha gene polymorphisms with risk for benign prostatic hyperplasia and prostate cancer in Chinese men.
Medicine 2017 Mar 96 (13): e6473.
Han Zihua, Zhang Lingzhi, Zhu Rujian, Luo Lifei, Zhu Min, Fan Lilong, Wang Guan